Sanger Sequencing Service Market Scope And Analysis

  • Report Code : TIPRE00007514
  • Category : Biotechnology
  • No. of Pages : 150
Buy Now

Sanger Sequencing Service Market Analysis Report 2024 to 2031

Buy Now


Sanger Sequencing Service Market Report Scope

Report Attribute Details
Market size in 2023 US$ 841.62 Million
Market Size by 2031 US$ 2,292.71 Million
Global CAGR (2023 - 2031) 13.3%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Application
  • Diagnostics
  • Biomarkers and Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Other Applications
By End User
  • Academic and Government Research Institutes
  • Biotechnology & Pharmaceutical Companies
  • Hospitals and Clinics
  • Other End Users
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Microsynth AG
  • Laragen Inc
  • StarSEQ GmbH
  • Thermo Fisher Scientific Inc
  • LGC Biosearch Technologies
  • Fasteris SA
  • Quintara Biosciences
  • GENEWIZ
  • GenScript
  • SciGenom Labs
  • Sanger Sequencing Service Market News and Recent Developments

    The Sanger sequencing service market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Sanger sequencing service market are listed below:

    • Source Genomics, a part of Source BioScience group opened new laboratory in the North of England in June 2023. This will provide Source Genomics industry-leading Sanger Sequencing service to the northern territory with faster turnaround times for optimised data delivery. ( Source: Source BioScience, Company Website, 2023)
    • Eurofins Genomics launched a revolutionary new, low-cost, whole plasmid sequencing service with same-day results. By leveraging Gen3 NGS (next generation sequencing) technology, this new service delivers a single-base accuracy of up to 99%. The new service, Whole Plasmid Sequencing, seeks to close the gap between Sanger and NGS by offering an affordable, fast solution for long-read sequencing. (Source: Eurofins Scientific, Company Website, 2023)
    • Thermo Fisher Scientific launched its latest generation of SeqStudio Flex Series Genetic Analyzer to enable customers' cutting-edge research in areas such as gene editing and infectious disease. Capillary Electrophoresis (CE), which enables Sanger sequencing and fragment analysis is an important tool for improving clinical research and advancing scientific discovery. The SeqStudio Flex Genetic Analyzer delivers the gold-standard quality of CE technology with accurate data and reliable performance. (Source: Business Standard, Newsletter, 2022)

    Sanger Sequencing Service Market Report Coverage and Deliverables

    The “Sanger Sequencing Service Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Sanger sequencing service market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Sanger sequencing service market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Sanger sequencing service market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Sanger sequencing service market
    • Detailed company profiles